DKY? #NRAS mutant melanoma is one of the most common and aggressive forms of melanoma, comprising ~20% of total cases. Our IMM-1-104 clinical trial is enrolling people with advanced solid tumors harboring RAS mutations, such as NRAS-mutant #melanoma. buff.ly/3hL4Z5r
